US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

4.83

-0.0500-1.02%

Post-market: 4.830.00000.00%19:15 EDT

Volume:294.27K

Turnover:1.43M

Market Cap:297.09M

PE:62.33

High:4.94

Open:4.93

Low:4.78

Close:4.88

Loading ...

Overview Company News Filings

Monte Rosa Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Monte Rosa Therapeutics Doses First Patients in Study of Inflammatory Disease Treatment

MT Newswires Live

Monte Rosa announces first subjects dosed in Phase 1 study of MRT-8102

BRIEF-Monte Rosa Therapeutics Announces First Subjects Dosed In Phase 1 Study Of Mrt-8102, A Nek7-Directed Molecular Glue Degrader For The Treatment Of Multiple Inflammatory Diseases

Piper Sandler Remains a Buy on Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics Inc. Conducted Annual Stockholders Meeting

BRIEF-Monte Rosa Therapeutics Announces FDA Clearance Of Ind Application For Mrt-8102

Edmund Dunn, Principal Accounting Officer, Reports Disposal of Common Shares in Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics: Promising Developments and Financial Stability Support Buy Rating

Monte Rosa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Monte Rosa Therapeutics Q1 EPS $0.57 Beats $(0.30) Estimate, Sales $84.93M Beat $14.25M Estimate

BRIEF-Monte Rosa Therapeutics Q1 Net Income USD 47.707 Million

Press Release: Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates

Monte Rosa Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Promising Developments in Cancer Treatment: Monte Rosa Therapeutics’ MRT-51443 Gains Buy Rating

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer

Monte Rosa Therapeutics Insider Ups Holding During Year

Simply Wall St.

Monte Rosa Therapeutics Is Maintained at Outperform by Wedbush

Wedbush Adjusts Price Target on Monte Rosa Therapeutics to $17 From $15, Maintains Outperform Rating

MT Newswires Live

Promising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GLUE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLUE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLUE\",,,,,undefined,":{"symbol":"GLUE","market":"US","secType":"STK","nameCN":"Monte Rosa Therapeutics","latestPrice":4.83,"timestamp":1754424000000,"preClose":4.88,"halted":0,"volume":294267,"hourTrading":{"tag":"盘后","latestPrice":4.83,"preClose":4.83,"latestTime":"19:15 EDT","volume":4571,"amount":22077.28,"timestamp":1754435732079},"delay":0,"floatShares":29133363,"shares":61509821,"eps":0.077485,"marketStatus":"Closed","change":-0.05,"latestTime":"08-05 16:00:00 EDT","open":4.93,"high":4.935,"low":4.78,"amount":1428576.0627378002,"amplitude":0.031762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.077485,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754467200000},"marketStatusCode":5,"adr":0,"listingDate":1624507200000,"exchange":"NASDAQ","adjPreClose":4.88,"preHourTrading":{"tag":"盘前","latestPrice":4.97,"preClose":4.88,"latestTime":"08:00 EDT","volume":10,"amount":49.699999999999996,"timestamp":1754395200683},"postHourTrading":{"tag":"盘后","latestPrice":4.83,"preClose":4.83,"latestTime":"19:15 EDT","volume":4571,"amount":22077.28,"timestamp":1754435732079},"volumeRatio":0.594292,"impliedVol":1.7581,"impliedVolPercentile":0.664},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLUE\",,,,,undefined,":{"symbol":"GLUE","floatShares":29133363,"roa":"-0.40%","roe":"2.88%","lyrEps":-0.983628,"volumeRatio":0.594292,"shares":61509821,"dividePrice":0,"high":4.935,"amplitude":0.031762,"preClose":4.88,"low":4.78,"week52Low":3.5001,"pbRate":"1.08","psRate":"1.86","week52High":12.4,"institutionHeld":0,"latestPrice":4.83,"eps":0.077485,"divideRate":0,"volume":294267,"delay":0,"ttmEps":0.077485,"open":4.93,"prevYearClose":6.94,"prevWeekClose":4.79,"prevMonthClose":4.95,"prevQuarterClose":4.51,"fiveDayClose":5.26,"twentyDayClose":5.06,"sixtyDayClose":4.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLUE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556384808","title":"Monte Rosa Therapeutics Inc  expected to post a loss of 39 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556384808","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556384808?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:54","pubTimestamp":1754312060,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics Inc  expected to post a loss of39cents a share - Earnings Preview Monte Rosa Therapeutics Inc GLUE.OQ GLUE.O is expected to  show a rise in quarterly revenue when it reports  r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"gpt_icon":0},{"id":"2553479412","title":"Monte Rosa Therapeutics Doses First Patients in Study of Inflammatory Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479412","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553479412?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:38","pubTimestamp":1753097905,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics  said Monday that the first patients have been dosed in its phase 1 study of MRT-8102 for the treatment of multiple inflammatory diseases.The study is designed to assess the safety and tolerability, pharmacokinetics, and pharmacodynamics of the drug in healthy volunteers, the company said.Monte Rosa said it expects the initial results of the study in H1 of 2026.The company's shares were up 6.2% in premarket activity on Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","GLUE","BK4139"],"gpt_icon":0},{"id":"2553479800","title":"Monte Rosa announces first subjects dosed in Phase 1 study of MRT-8102","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479800","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553479800?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:17","pubTimestamp":1753096662,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (GLUE) announced that the first subjects have been dosed in a Phase 1 study evaluating MRT-8102, a NEK7-directed MGD being ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monte-rosa-announces-first-subjects-dosed-in-phase-1-study-of-mrt-8102-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monte-rosa-announces-first-subjects-dosed-in-phase-1-study-of-mrt-8102-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4230","MRT","BK4539","GLUE","BK4139"],"gpt_icon":0},{"id":"2553347699","title":"BRIEF-Monte Rosa Therapeutics Announces First Subjects Dosed In Phase 1 Study Of Mrt-8102, A Nek7-Directed Molecular Glue Degrader For The Treatment Of Multiple Inflammatory Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2553347699","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553347699?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:01","pubTimestamp":1753095681,"startTime":"0","endTime":"0","summary":"BRIEF-Monte Rosa Therapeutics Announces First Subjects Dosed In Phase 1 Study Of Mrt-8102, A Nek7-Directed Molecular Glue Degrader For The Treatment Of Multiple Inflammatory DiseasesJuly 21 (Reuters) ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nTUA5BCTVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","BK4539","BK4139"],"gpt_icon":0},{"id":"2549218539","title":"Piper Sandler Remains a Buy on Monte Rosa Therapeutics (GLUE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549218539","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549218539?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:16","pubTimestamp":1751886963,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Monte Rosa Therapeutics today and set a price target of $20.00. The company’s shar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-monte-rosa-therapeutics-glue-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-monte-rosa-therapeutics-glue-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","GLUE","BK4139"],"gpt_icon":0},{"id":"2543637609","title":"Monte Rosa Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543637609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543637609?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:03","pubTimestamp":1749845003,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on June 13, 2025. During the meeting, stockholders voted on two key proposals. The first proposal was to elect Christine Siu, Kimberly Blackwell, and Jan Skvarka as Class I directors of the company, which was approved. The second proposal was to ratify the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, which was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securitie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDLtGWBy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","GLUE"],"gpt_icon":0},{"id":"2542031645","title":"BRIEF-Monte Rosa Therapeutics Announces FDA Clearance Of Ind Application For Mrt-8102","url":"https://stock-news.laohu8.com/highlight/detail?id=2542031645","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542031645?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:12","pubTimestamp":1749553966,"startTime":"0","endTime":"0","summary":"BRIEF-Monte Rosa Therapeutics Announces FDA Clearance Of Ind Application For Mrt-8102June 10 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O:MONTE ROSA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nTUABLW9VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","GLUE"],"gpt_icon":0},{"id":"2541096702","title":"Edmund Dunn, Principal Accounting Officer, Reports Disposal of Common Shares in Monte Rosa Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541096702","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541096702?lang=en_us&edition=fundamental","pubTime":"2025-06-05 04:15","pubTimestamp":1749068144,"startTime":"0","endTime":"0","summary":"Edmund Dunn, Principal Accounting Officer, reported a disposal of common shares of Monte Rosa Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLcc37zb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edmund Dunn, Principal Accounting Officer, Reports Disposal of Common Shares in Monte Rosa Therapeutics Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLUE","BK4539"],"gpt_icon":0},{"id":"2534168150","title":"Monte Rosa Therapeutics: Promising Developments and Financial Stability Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2534168150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534168150?lang=en_us&edition=fundamental","pubTime":"2025-05-09 02:55","pubTimestamp":1746730547,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm has maintained their bullish stance on GLUE stock, giving a Buy rating on April 29. Marc Frahm has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/monte-rosa-therapeutics-promising-developments-and-financial-stability-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/monte-rosa-therapeutics-promising-developments-and-financial-stability-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLUE"],"gpt_icon":0},{"id":"2533137036","title":"Monte Rosa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533137036","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533137036?lang=en_us&edition=fundamental","pubTime":"2025-05-08 23:08","pubTimestamp":1746716938,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryMonte Rosa Therapeutics Inc GLUE.OQ reported quarterly adjusted earnings of 56 cents per share for the quar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG2KI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"gpt_icon":1},{"id":"2533267185","title":"Monte Rosa Therapeutics Q1 EPS $0.57 Beats $(0.30) Estimate, Sales $84.93M Beat $14.25M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533267185","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533267185?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:24","pubTimestamp":1746703442,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $(0.30) by 290 percent. This is a 207.55 percent increase over losses of $(0.53) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45281563/monte-rosa-therapeutics-q1-eps-0-57-beats-0-30-estimate-sales-84-93m-beat-14-25m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"gpt_icon":0},{"id":"2533887631","title":"BRIEF-Monte Rosa Therapeutics Q1 Net Income USD 47.707 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533887631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533887631?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:00","pubTimestamp":1746702045,"startTime":"0","endTime":"0","summary":"BRIEF-Monte Rosa Therapeutics Q1 Net Income USD 47.707 Million\n\n\nMay 08 (Reuters) - Monte Rosa Therapeutics Q1 operating income USD 44.036 million.\n\nQ1 operating expenses USD 40.893 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLX290B81:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","BK4139","BK4539"],"gpt_icon":0},{"id":"2533188211","title":"Press Release: Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533188211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533188211?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:00","pubTimestamp":1746702000,"startTime":"0","endTime":"0","summary":"VAV1-directed MRT-6160 program advancing toward multiple Phase 2 studies, enabled by Phase 1 SAD/MAD study data supporting broad potential application in immune-mediated diseases. MRT-2359 Phase 1/2 study data demonstrate encouraging signals of clinical response in heavily pretreated castration-resistant prostate cancer patients resistant to AR therapy; additional results expected in H2 2025. MRT-8102, a NEK7-directed molecular glue degrader targeting diseases driven by IL-1<BETA> and the NLRP3 inflammasome, on track for IND filing in H1 2025. Cyclin E1  and CDK2-directed MGD programs for the treatment of CCNE1-driven solid tumors and ER+ breast cancer advancing toward the clinic; IND submission anticipated in 2026. -- In March 2025, Monte Rosa announced clinical resul","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TM","BK4555","AR","03160","BK4539","BK4604","GLUE","BK4585","BK4213","BK4588","BK4099"],"gpt_icon":0},{"id":"2533581394","title":"Monte Rosa Therapeutics Inc  expected to post a loss of 34 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581394?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:46","pubTimestamp":1746449164,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics Inc  expected to post a loss of34cents a share - Earnings Preview Monte Rosa Therapeutics Inc GLUE.OQ GLUE.O is expected to show a rise in quarterly revenue when it reports  re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"gpt_icon":0},{"id":"2531738011","title":"Promising Developments in Cancer Treatment: Monte Rosa Therapeutics’ MRT-51443 Gains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2531738011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531738011?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:16","pubTimestamp":1745928967,"startTime":"0","endTime":"0","summary":"Analyst Oliver McCammon from LifeSci Capital maintained a Buy rating on Monte Rosa Therapeutics (GLUE – Research Report) and keeping the price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-cancer-treatment-monte-rosa-therapeutics-mrt-51443-gains-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-cancer-treatment-monte-rosa-therapeutics-mrt-51443-gains-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRT","GLUE"],"gpt_icon":0},{"id":"2530364472","title":"Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530364472","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530364472?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:00","pubTimestamp":1745838000,"startTime":"0","endTime":"0","summary":"CDK2 molecular glue degrader  in combination with CDK4/6 inhibition and anti-estrogen therapy achieved superior tumor regression in vivo compared to standard of care CDK4/6 inhibition and anti-estrogen therapy. CDK2 MGD delayed resistance to CDK4/6 inhibition in vitro and displayed superior selectivity versus clinical-stage CDK2 inhibitors. “In preclinical models of HR-positive/HER2-negative breast cancer, the combination of MRT-51443 with a CDK4/6 inhibitor and anti-estrogen therapy drove robust tumor regressions, demonstrating notably deeper tumor responses than the standard of care combination alone,” said Sharon Townson, Ph.D., Chief Scientific Officer of Monte Rosa Therapeutics. “These results suggest that our highly selective, oral CDK2 degrader MRT-51443 has the potential to improve on current standard of care therapy for HR-positive/HER2-negative breast cancer. In addition, we believe our MGD approach could avoid many of the toxicities associated with less selective CDK2 inhibi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monte-rosa-therapeutics-presents-preclinical-110000440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4117","HR","GLUE","AFG","BK4107","BK4203","BK4225","BK4539","BK4139"],"gpt_icon":0},{"id":"2529684558","title":"Monte Rosa Therapeutics Insider Ups Holding During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684558","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529684558?lang=en_us&edition=fundamental","pubTime":"2025-04-23 01:35","pubTimestamp":1745343307,"startTime":"0","endTime":"0","summary":"From what we can see, insiders were net buyers in Monte Rosa Therapeutics, Inc.'s  during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Monte Rosa Therapeutics insiders are expecting a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 3 warning signs for Monte Rosa Therapeutics you sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monte-rosa-therapeutics-insider-ups-173507298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GLUE","BK4539","BK4139"],"gpt_icon":0},{"id":"2521233813","title":"Monte Rosa Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2521233813","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521233813?lang=en_us&edition=fundamental","pubTime":"2025-03-21 22:35","pubTimestamp":1742567700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLUE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 10:35 ET (14:35 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"gpt_icon":0},{"id":"2521285590","title":"Wedbush Adjusts Price Target on Monte Rosa Therapeutics to $17 From $15, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2521285590","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521285590?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:27","pubTimestamp":1742560071,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (GLUE) has an average rating of buy and mean price target of $15.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLUE"],"gpt_icon":0},{"id":"2521884022","title":"Promising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2521884022","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521884022?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:55","pubTimestamp":1742558130,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Oliver McCammon maintained a Buy rating on Monte Rosa Therapeutics (GLUE – Research Report) today and set a price target of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-partnerships-drive-buy-rating-for-monte-rosa-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-strategic-partnerships-drive-buy-rating-for-monte-rosa-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLUE"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLUE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"GLUE","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.57},{"market":"US","date":"2021-08-12","symbol":"GLUE","fiscalQuarterEnding":"2021/06","expectedEps":-0.41,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.63}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLUE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLUE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1741838400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLUE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLUE","date":"2025-08-04","current":47.884291,"percent":0.97271,"low":-34.321574,"twenty":-7.70704,"median":-3.336303,"eighty":-2.088595,"high":59.580454,"avg":-2.856699,"sd":14.144195,"marketCap":294632042},"quantilePoints":[{"date":"2021-06-25","current":-19.134049,"twenty":-20.160754,"median":-19.276083,"eighty":-19.219269,"marketCap":839085454},{"date":"2021-07-02","current":-22.553018,"twenty":-22.557076,"median":-20.270323,"eighty":-19.276083,"marketCap":989017479},{"date":"2021-07-09","current":-19.610879,"twenty":-22.130973,"median":-20.138434,"eighty":-19.324781,"marketCap":859995855},{"date":"2021-07-16","current":-19.570297,"twenty":-21.493848,"median":-19.590588,"eighty":-19.276083,"marketCap":858216247},{"date":"2021-07-23","current":-23.709583,"twenty":-22.299385,"median":-20.107999,"eighty":-19.324781,"marketCap":1039736324},{"date":"2021-07-30","current":-24.876293,"twenty":-22.899987,"median":-20.879041,"eighty":-19.397827,"marketCap":1090900071},{"date":"2021-08-06","current":-31.115657,"twenty":-23.782629,"median":-21.81241,"eighty":-19.446525,"marketCap":1364514894},{"date":"2021-08-13","current":-26.765116,"twenty":-26.476271,"median":-22.517509,"eighty":-19.539861,"marketCap":1522774483},{"date":"2021-08-20","current":-27.888902,"twenty":-26.969297,"median":-22.705197,"eighty":-19.58653,"marketCap":1586711200},{"date":"2021-08-27","current":-30.548003,"twenty":-29.59041,"median":-23.242898,"eighty":-19.732623,"marketCap":1737998080},{"date":"2021-09-03","current":-33.404953,"twenty":-29.94654,"median":-23.831326,"eighty":-19.992342,"marketCap":1900541423},{"date":"2021-09-10","current":-27.62774,"twenty":-29.970282,"median":-25.514705,"eighty":-20.114086,"marketCap":1571852667},{"date":"2021-09-17","current":-24.319692,"twenty":-29.865817,"median":-25.514705,"eighty":-20.164812,"marketCap":1383644585},{"date":"2021-09-24","current":-18.898609,"twenty":-29.783512,"median":-24.876293,"eighty":-19.760379,"marketCap":1075217465},{"date":"2021-10-01","current":-15.883379,"twenty":-29.531847,"median":-23.770454,"eighty":-19.525168,"marketCap":903668949},{"date":"2021-10-08","current":-14.078989,"twenty":-29.036431,"median":-23.151591,"eighty":-19.353,"marketCap":801009996},{"date":"2021-10-15","current":-16.77766,"twenty":-28.21021,"median":-22.63418,"eighty":-19.085351,"marketCap":954548168},{"date":"2021-10-22","current":-18.059726,"twenty":-28.061007,"median":-22.482,"eighty":-18.846594,"marketCap":1027490056},{"date":"2021-10-29","current":-18.558307,"twenty":-27.994851,"median":-21.655158,"eighty":-18.811555,"marketCap":1055856346},{"date":"2021-11-05","current":-20.03031,"twenty":-27.843001,"median":-21.486484,"eighty":-18.846594,"marketCap":1139604440},{"date":"2021-11-12","current":-16.693989,"twenty":-27.653065,"median":-20.857321,"eighty":-18.476002,"marketCap":1171483973},{"date":"2021-11-19","current":-12.969486,"twenty":-27.523275,"median":-20.489321,"eighty":-17.88087,"marketCap":910120736},{"date":"2021-11-26","current":-13.618955,"twenty":-27.105417,"median":-20.138434,"eighty":-17.339553,"marketCap":955696532},{"date":"2021-12-03","current":-10.789128,"twenty":-26.765116,"median":-20.069154,"eighty":-16.316237,"marketCap":757116279},{"date":"2021-12-10","current":-11.630786,"twenty":-26.638492,"median":-19.721664,"eighty":-15.543077,"marketCap":816178790},{"date":"2021-12-17","current":-12.286882,"twenty":-26.33776,"median":-19.590588,"eighty":-15.13155,"marketCap":862219645},{"date":"2021-12-23","current":-13.877417,"twenty":-26.23013,"median":-19.533563,"eighty":-14.4214,"marketCap":973833839},{"date":"2021-12-31","current":-13.532801,"twenty":-26.075047,"median":-19.397827,"eighty":-13.804517,"marketCap":949650763},{"date":"2022-01-07","current":-11.299425,"twenty":-25.905269,"median":-19.308938,"eighty":-13.408209,"marketCap":792925833},{"date":"2022-01-14","current":-9.940843,"twenty":-25.674568,"median":-19.134049,"eighty":-12.966835,"marketCap":697588710},{"date":"2022-01-21","current":-8.482853,"twenty":-25.559023,"median":-19.073177,"eighty":-12.738859,"marketCap":595275699},{"date":"2022-01-28","current":-7.111016,"twenty":-25.514705,"median":-18.879368,"eighty":-12.278929,"marketCap":499008457},{"date":"2022-02-04","current":-8.529243,"twenty":-25.253544,"median":-18.803641,"eighty":-11.885272,"marketCap":598531113},{"date":"2022-02-11","current":-8.648533,"twenty":-24.95755,"median":-18.447512,"eighty":-11.670549,"marketCap":606902177},{"date":"2022-02-18","current":-9.013031,"twenty":-24.542332,"median":-17.925188,"eighty":-11.445224,"marketCap":632480430},{"date":"2022-02-25","current":-9.993861,"twenty":-24.124346,"median":-17.632371,"eighty":-11.211945,"marketCap":701309183},{"date":"2022-03-04","current":-8.641906,"twenty":-23.782629,"median":-17.299983,"eighty":-10.530666,"marketCap":606437118},{"date":"2022-03-11","current":-9.463682,"twenty":-23.559432,"median":-16.693989,"eighty":-9.96205,"marketCap":664104451},{"date":"2022-03-18","current":-9.258238,"twenty":-23.26116,"median":-16.061443,"eighty":-9.601529,"marketCap":649687618},{"date":"2022-03-25","current":-7.43575,"twenty":-23.102893,"median":-15.543077,"eighty":-9.474286,"marketCap":521796355},{"date":"2022-04-01","current":-9.229506,"twenty":-22.899987,"median":-15.21083,"eighty":-9.343067,"marketCap":682595781},{"date":"2022-04-08","current":-8.094628,"twenty":-22.648383,"median":-15.110081,"eighty":-9.247635,"marketCap":598662468},{"date":"2022-04-14","current":-8.571151,"twenty":-22.561134,"median":-14.507003,"eighty":-9.188871,"marketCap":633905185},{"date":"2022-04-22","current":-7.837556,"twenty":-22.538814,"median":-13.973512,"eighty":-9.036889,"marketCap":579649950},{"date":"2022-04-29","current":-6.838169,"twenty":-22.390692,"median":-13.618955,"eighty":-8.845017,"marketCap":505737328},{"date":"2022-05-06","current":-7.258497,"twenty":-21.982852,"median":-13.469842,"eighty":-8.788285,"marketCap":536823934},{"date":"2022-05-13","current":-4.44298,"twenty":-21.749509,"median":-13.340611,"eighty":-8.643231,"marketCap":380381257},{"date":"2022-05-20","current":-4.529778,"twenty":-21.495877,"median":-12.962859,"eighty":-8.557578,"marketCap":387812393},{"date":"2022-05-27","current":-4.394156,"twenty":-21.487505,"median":-12.757415,"eighty":-8.408627,"marketCap":376201243},{"date":"2022-06-03","current":-4.171735,"twenty":-21.486484,"median":-12.512208,"eighty":-8.317172,"marketCap":357158958},{"date":"2022-06-10","current":-3.987289,"twenty":-21.431086,"median":-12.276941,"eighty":-8.157328,"marketCap":341367795},{"date":"2022-06-17","current":-3.737745,"twenty":-21.027472,"median":-12.061556,"eighty":-7.988037,"marketCap":320003280},{"date":"2022-06-24","current":-5.555081,"twenty":-20.755231,"median":-11.829603,"eighty":-7.852775,"marketCap":475592683},{"date":"2022-07-01","current":-5.484557,"twenty":-20.623859,"median":-11.723567,"eighty":-7.615655,"marketCap":469554885},{"date":"2022-07-08","current":-6.363388,"twenty":-20.536805,"median":-11.610905,"eighty":-7.507923,"marketCap":544795134},{"date":"2022-07-15","current":-5.560506,"twenty":-20.357922,"median":-11.511496,"eighty":-7.294353,"marketCap":476057129},{"date":"2022-07-22","current":-5.734102,"twenty":-20.19119,"median":-11.289484,"eighty":-7.062104,"marketCap":490919400},{"date":"2022-07-29","current":-4.920369,"twenty":-20.125792,"median":-10.954809,"eighty":-6.568449,"marketCap":421252503},{"date":"2022-08-05","current":-5.028867,"twenty":-20.111745,"median":-10.573743,"eighty":-6.265809,"marketCap":430541423},{"date":"2022-08-12","current":-4.981337,"twenty":-20.061386,"median":-10.000488,"eighty":-5.808965,"marketCap":466641657},{"date":"2022-08-19","current":-4.469794,"twenty":-19.961267,"median":-9.920962,"eighty":-5.729762,"marketCap":418721328},{"date":"2022-08-26","current":-4.276103,"twenty":-19.799094,"median":-9.609481,"eighty":-5.558336,"marketCap":400576737},{"date":"2022-09-02","current":-4.007915,"twenty":-19.721664,"median":-9.539896,"eighty":-5.398844,"marketCap":375453457},{"date":"2022-09-09","current":-4.499592,"twenty":-19.67735,"median":-9.476937,"eighty":-5.213313,"marketCap":421512803},{"date":"2022-09-16","current":-3.560936,"twenty":-19.594646,"median":-9.417292,"eighty":-5.015848,"marketCap":333581324},{"date":"2022-09-23","current":-3.620533,"twenty":-19.561201,"median":-9.347706,"eighty":-4.926877,"marketCap":339164275},{"date":"2022-09-30","current":-4.057579,"twenty":-19.536362,"median":-9.251611,"eighty":-4.748116,"marketCap":380105916},{"date":"2022-10-07","current":-3.620533,"twenty":-19.508606,"median":-9.237245,"eighty":-4.620073,"marketCap":339164275},{"date":"2022-10-14","current":-3.858922,"twenty":-19.454426,"median":-9.145575,"eighty":-4.526566,"marketCap":361496079},{"date":"2022-10-21","current":-3.863888,"twenty":-19.397827,"median":-9.072676,"eighty":-4.487672,"marketCap":361961325},{"date":"2022-10-28","current":-4.310868,"twenty":-19.375413,"median":-8.933504,"eighty":-4.453706,"marketCap":403833458},{"date":"2022-11-04","current":-4.087378,"twenty":-19.315509,"median":-8.817726,"eighty":-4.438209,"marketCap":382897392},{"date":"2022-11-11","current":-4.3395,"twenty":-19.276083,"median":-8.790603,"eighty":-4.412183,"marketCap":438979437},{"date":"2022-11-18","current":-4.396913,"twenty":-19.219269,"median":-8.708993,"eighty":-4.412183,"marketCap":444787324},{"date":"2022-11-25","current":-4.057217,"twenty":-19.132862,"median":-8.645219,"eighty":-4.38315,"marketCap":410423994},{"date":"2022-12-02","current":-4.650489,"twenty":-19.117127,"median":-8.571151,"eighty":-4.316594,"marketCap":470438824},{"date":"2022-12-09","current":-4.105061,"twenty":-19.055674,"median":-8.542497,"eighty":-4.31181,"marketCap":415263900},{"date":"2022-12-16","current":-4.38256,"twenty":-18.968252,"median":-8.482853,"eighty":-4.31181,"marketCap":443335352},{"date":"2022-12-23","current":-3.798856,"twenty":-18.890912,"median":-8.331837,"eighty":-4.235803,"marketCap":384288504},{"date":"2022-12-30","current":-3.640969,"twenty":-18.860126,"median":-8.310544,"eighty":-4.205535,"marketCap":368316816},{"date":"2023-01-06","current":-3.808425,"twenty":-18.846594,"median":-8.213759,"eighty":-4.17065,"marketCap":385256485},{"date":"2023-01-13","current":-3.736658,"twenty":-18.811555,"median":-8.094628,"eighty":-4.139059,"marketCap":377996627},{"date":"2023-01-20","current":-3.478298,"twenty":-18.656441,"median":-7.994307,"eighty":-4.126116,"marketCap":351861137},{"date":"2023-01-27","current":-3.564418,"twenty":-18.496578,"median":-7.966092,"eighty":-4.102277,"marketCap":360572967},{"date":"2023-02-03","current":-3.928037,"twenty":-18.445929,"median":-7.837556,"eighty":-4.071715,"marketCap":397356249},{"date":"2023-02-10","current":-3.301273,"twenty":-18.211675,"median":-7.650069,"eighty":-4.050353,"marketCap":333953486},{"date":"2023-02-17","current":-3.301273,"twenty":-17.979003,"median":-7.52826,"eighty":-4.031089,"marketCap":333953486},{"date":"2023-02-24","current":-2.908948,"twenty":-17.903029,"median":-7.496892,"eighty":-4.008498,"marketCap":294266260},{"date":"2023-03-03","current":-3.021383,"twenty":-17.774822,"median":-7.375355,"eighty":-3.988467,"marketCap":305640038},{"date":"2023-03-10","current":-2.875457,"twenty":-17.562728,"median":-7.258497,"eighty":-3.954278,"marketCap":290878326},{"date":"2023-03-17","current":-3.27637,"twenty":-17.410779,"median":-7.049876,"eighty":-3.928452,"marketCap":355489421},{"date":"2023-03-24","current":-3.05855,"twenty":-17.307897,"median":-6.838169,"eighty":-3.917008,"marketCap":331855775},{"date":"2023-03-31","current":-3.535031,"twenty":-17.067312,"median":-6.444762,"eighty":-3.890707,"marketCap":383554375},{"date":"2023-04-06","current":-3.55772,"twenty":-16.760926,"median":-6.311852,"eighty":-3.859915,"marketCap":386016214},{"date":"2023-04-14","current":-3.435333,"twenty":-16.618439,"median":-6.010771,"eighty":-3.814987,"marketCap":372737057},{"date":"2023-04-21","current":-2.741005,"twenty":-16.300891,"median":-5.804626,"eighty":-3.783338,"marketCap":297401826},{"date":"2023-04-28","current":-2.056248,"twenty":-16.168282,"median":-5.744952,"eighty":-3.756614,"marketCap":223104955},{"date":"2023-05-05","current":-2.255972,"twenty":-15.843809,"median":-5.669003,"eighty":-3.725176,"marketCap":244775193},{"date":"2023-05-12","current":-2.470827,"twenty":-15.657039,"median":-5.560506,"eighty":-3.692043,"marketCap":288115670},{"date":"2023-05-19","current":-2.341989,"twenty":-15.495593,"median":-5.495407,"eighty":-3.672963,"marketCap":273092261},{"date":"2023-05-26","current":-2.587179,"twenty":-15.293051,"median":-5.310961,"eighty":-3.637142,"marketCap":301683147},{"date":"2023-06-02","current":-3.191699,"twenty":-15.242626,"median":-5.245862,"eighty":-3.620533,"marketCap":372174471},{"date":"2023-06-09","current":-2.79855,"twenty":-15.179034,"median":-5.148214,"eighty":-3.55772,"marketCap":326330463},{"date":"2023-06-16","current":-3.124061,"twenty":-15.13155,"median":-5.007168,"eighty":-3.535031,"marketCap":364287330},{"date":"2023-06-23","current":-2.883098,"twenty":-15.114375,"median":-4.963768,"eighty":-3.480838,"marketCap":336189390},{"date":"2023-06-30","current":-2.849279,"twenty":-14.768116,"median":-4.920369,"eighty":-3.448117,"marketCap":332245819},{"date":"2023-07-07","current":-2.675954,"twenty":-14.526885,"median":-4.860696,"eighty":-3.413944,"marketCap":312035020},{"date":"2023-07-14","current":-3.031057,"twenty":-14.335797,"median":-4.706086,"eighty":-3.350075,"marketCap":353442511},{"date":"2023-07-21","current":-2.942282,"twenty":-14.075236,"median":-4.650489,"eighty":-3.337601,"marketCap":343090638},{"date":"2023-07-28","current":-2.857733,"twenty":-13.99273,"median":-4.609544,"eighty":-3.286331,"marketCap":333231712},{"date":"2023-08-04","current":-2.840824,"twenty":-13.866813,"median":-4.549257,"eighty":-3.262997,"marketCap":331259927},{"date":"2023-08-11","current":-2.647103,"twenty":-13.758127,"median":-4.527101,"eighty":-3.237161,"marketCap":331724377},{"date":"2023-08-18","current":-2.528221,"twenty":-13.584493,"median":-4.519458,"eighty":-3.201703,"marketCap":316826576},{"date":"2023-08-25","current":-2.540109,"twenty":-13.53015,"median":-4.509347,"eighty":-3.178351,"marketCap":318316356},{"date":"2023-09-01","current":-2.326122,"twenty":-13.481109,"median":-4.499592,"eighty":-3.139233,"marketCap":291500314},{"date":"2023-09-08","current":-2.377638,"twenty":-13.408209,"median":-4.479726,"eighty":-3.120679,"marketCap":297956028},{"date":"2023-09-15","current":-2.389526,"twenty":-13.377724,"median":-4.469949,"eighty":-3.079513,"marketCap":299445808},{"date":"2023-09-22","current":-2.433116,"twenty":-13.274339,"median":-4.44298,"eighty":-3.053696,"marketCap":304908335},{"date":"2023-09-29","current":-1.894185,"twenty":-13.001297,"median":-4.435109,"eighty":-3.040423,"marketCap":237371635},{"date":"2023-10-06","current":-1.803042,"twenty":-12.966835,"median":-4.43213,"eighty":-3.021861,"marketCap":225949987},{"date":"2023-10-13","current":-1.886259,"twenty":-12.935025,"median":-4.415163,"eighty":-2.989629,"marketCap":236378448},{"date":"2023-10-20","current":-1.238353,"twenty":-12.83164,"median":-4.394156,"eighty":-2.968346,"marketCap":155185431},{"date":"2023-10-27","current":-0.990682,"twenty":-12.794527,"median":-4.38256,"eighty":-2.963419,"marketCap":124148345},{"date":"2023-11-03","current":-1.375067,"twenty":-12.72958,"median":-4.364906,"eighty":-2.947224,"marketCap":172317902},{"date":"2023-11-10","current":-1.233243,"twenty":-12.591734,"median":-4.320362,"eighty":-2.929599,"marketCap":163875815},{"date":"2023-11-17","current":-1.220627,"twenty":-12.388942,"median":-4.300975,"eighty":-2.908754,"marketCap":162199376},{"date":"2023-11-24","current":-1.118908,"twenty":-12.298811,"median":-4.264741,"eighty":-2.899162,"marketCap":148682761},{"date":"2023-12-01","current":-1.167884,"twenty":-12.278929,"median":-4.220559,"eighty":-2.874969,"marketCap":155190761},{"date":"2023-12-08","current":-1.382624,"twenty":-12.216633,"median":-4.202198,"eighty":-2.852661,"marketCap":183725837},{"date":"2023-12-15","current":-1.876149,"twenty":-12.109272,"median":-4.171735,"eighty":-2.835751,"marketCap":249306449},{"date":"2023-12-21","current":-2.034379,"twenty":-12.033722,"median":-4.161875,"eighty":-2.801932,"marketCap":270332294},{"date":"2023-12-29","current":-2.234049,"twenty":-11.950218,"median":-4.147323,"eighty":-2.779949,"marketCap":296864908},{"date":"2024-01-05","current":-2.29056,"twenty":-11.885272,"median":-4.138553,"eighty":-2.745422,"marketCap":304374138},{"date":"2024-01-12","current":-2.320699,"twenty":-11.829603,"median":-4.124626,"eighty":-2.696246,"marketCap":308379061},{"date":"2024-01-19","current":-1.928892,"twenty":-11.813698,"median":-4.108636,"eighty":-2.660736,"marketCap":256315064},{"date":"2024-01-26","current":-2.181306,"twenty":-11.739472,"median":-4.102277,"eighty":-2.626219,"marketCap":289856293},{"date":"2024-02-02","current":-1.864847,"twenty":-11.683804,"median":-4.084259,"eighty":-2.589287,"marketCap":247804603},{"date":"2024-02-09","current":-1.766895,"twenty":-11.622833,"median":-4.057217,"eighty":-2.544864,"marketCap":234788603},{"date":"2024-02-16","current":-2.083354,"twenty":-11.580419,"median":-4.049788,"eighty":-2.51554,"marketCap":276840294},{"date":"2024-02-23","current":-2.117261,"twenty":-11.538005,"median":-4.038079,"eighty":-2.488594,"marketCap":281345832},{"date":"2024-03-01","current":-2.384744,"twenty":-11.511496,"median":-4.027781,"eighty":-2.470827,"marketCap":316889522},{"date":"2024-03-08","current":-2.215212,"twenty":-11.345815,"median":-4.008643,"eighty":-2.445485,"marketCap":294361831},{"date":"2024-03-15","current":-2.255961,"twenty":-11.299425,"median":-4.002949,"eighty":-2.409339,"marketCap":305348805},{"date":"2024-03-22","current":-2.811616,"twenty":-11.279543,"median":-3.985186,"eighty":-2.409339,"marketCap":380557871},{"date":"2024-03-28","current":-2.607876,"twenty":-11.189413,"median":-3.968184,"eighty":-2.428361,"marketCap":352981214},{"date":"2024-04-05","current":-2.604171,"twenty":-10.997223,"median":-3.938385,"eighty":-2.439456,"marketCap":352479820},{"date":"2024-04-12","current":-2.656033,"twenty":-10.9283,"median":-3.928452,"eighty":-2.441151,"marketCap":359499333},{"date":"2024-04-19","current":-2.192987,"twenty":-10.815637,"median":-3.927616,"eighty":-2.428361,"marketCap":296825111},{"date":"2024-04-26","current":-2.018881,"twenty":-10.444512,"median":-3.908587,"eighty":-2.396254,"marketCap":273259604},{"date":"2024-05-03","current":-2.081532,"twenty":-10.103872,"median":-3.893687,"eighty":-2.391269,"marketCap":281739516},{"date":"2024-05-10","current":-1.926413,"twenty":-10.008441,"median":-3.873821,"eighty":-2.384115,"marketCap":260609053},{"date":"2024-05-17","current":-2.359171,"twenty":-9.995186,"median":-3.853955,"eighty":-2.378352,"marketCap":319153357},{"date":"2024-05-24","current":-1.803274,"twenty":-9.951447,"median":-3.819703,"eighty":-2.372696,"marketCap":243950555},{"date":"2024-05-31","current":-1.862028,"twenty":-9.916985,"median":-3.806358,"eighty":-2.368104,"marketCap":251898818},{"date":"2024-06-07","current":-1.798755,"twenty":-9.793718,"median":-3.779459,"eighty":-2.355212,"marketCap":243339150},{"date":"2024-06-14","current":-1.730963,"twenty":-9.654546,"median":-3.767355,"eighty":-2.335642,"marketCap":234168076},{"date":"2024-06-21","current":-1.640573,"twenty":-9.604179,"median":-3.746186,"eighty":-2.315484,"marketCap":221939978},{"date":"2024-06-28","current":-1.690287,"twenty":-9.588274,"median":-3.736658,"eighty":-2.260797,"marketCap":228665432},{"date":"2024-07-05","current":-1.645092,"twenty":-9.561765,"median":-3.714895,"eighty":-2.253501,"marketCap":222551383},{"date":"2024-07-12","current":-1.952417,"twenty":-9.500795,"median":-3.696127,"eighty":-2.234668,"marketCap":264126916},{"date":"2024-07-19","current":-1.9253,"twenty":-9.484889,"median":-3.688814,"eighty":-2.215212,"marketCap":260458487},{"date":"2024-07-26","current":-2.110599,"twenty":-9.463682,"median":-3.667714,"eighty":-2.183642,"marketCap":285526088},{"date":"2024-08-02","current":-1.812313,"twenty":-9.454404,"median":-3.640969,"eighty":-2.154934,"marketCap":245173364},{"date":"2024-08-09","current":-1.854003,"twenty":-9.413593,"median":-3.620892,"eighty":-2.14125,"marketCap":241787985},{"date":"2024-08-16","current":-2.202217,"twenty":-9.393218,"median":-3.593125,"eighty":-2.132558,"marketCap":287199942},{"date":"2024-08-23","current":-2.97864,"twenty":-9.361623,"median":-3.559328,"eighty":-2.14125,"marketCap":388456331},{"date":"2024-08-30","current":-2.90335,"twenty":-9.311256,"median":-3.540496,"eighty":-2.143496,"marketCap":378637530},{"date":"2024-09-06","current":-2.677482,"twenty":-9.258238,"median":-3.535031,"eighty":-2.148534,"marketCap":349181126},{"date":"2024-09-13","current":-2.861,"twenty":-9.251611,"median":-3.491846,"eighty":-2.151167,"marketCap":373114454},{"date":"2024-09-20","current":-3.049224,"twenty":-9.244984,"median":-3.45916,"eighty":-2.154934,"marketCap":397661458},{"date":"2024-09-27","current":-2.432791,"twenty":-9.244984,"median":-3.428109,"eighty":-2.154934,"marketCap":317270021},{"date":"2024-10-04","current":-2.395146,"twenty":-9.229506,"median":-3.412507,"eighty":-2.162469,"marketCap":312360620},{"date":"2024-10-11","current":-2.319857,"twenty":-9.178712,"median":-3.381127,"eighty":-2.167056,"marketCap":302541819},{"date":"2024-10-18","current":-2.597487,"twenty":-9.145575,"median":-3.339901,"eighty":-2.181306,"marketCap":338748649},{"date":"2024-10-25","current":-2.301035,"twenty":-9.145575,"median":-3.337926,"eighty":-2.192987,"marketCap":300087119},{"date":"2024-11-01","current":-4.187977,"twenty":-9.132321,"median":-3.339901,"eighty":-2.200989,"marketCap":546170830},{"date":"2024-11-08","current":-4.765082,"twenty":-9.013031,"median":-3.381127,"eighty":-2.202217,"marketCap":568898434},{"date":"2024-11-15","current":-3.982909,"twenty":-8.986522,"median":-3.412507,"eighty":-2.207911,"marketCap":475515537},{"date":"2024-11-22","current":-4.36885,"twenty":-8.933504,"median":-3.428109,"eighty":-2.215212,"marketCap":521592624},{"date":"2024-11-29","current":-5.331129,"twenty":-8.896392,"median":-3.4579,"eighty":-2.215212,"marketCap":636478161},{"date":"2024-12-06","current":-4.842271,"twenty":-8.845017,"median":-3.481473,"eighty":-2.224686,"marketCap":578113851},{"date":"2024-12-13","current":-3.890283,"twenty":-8.807667,"median":-3.533084,"eighty":-2.2284,"marketCap":464457036},{"date":"2024-12-20","current":-3.566093,"twenty":-8.795658,"median":-3.535031,"eighty":-2.232987,"marketCap":425752283},{"date":"2024-12-27","current":-3.632989,"twenty":-8.792095,"median":-3.554849,"eighty":-2.235907,"marketCap":433738978},{"date":"2025-01-03","current":-3.689594,"twenty":-8.789444,"median":-3.560936,"eighty":-2.240226,"marketCap":440496951},{"date":"2025-01-10","current":-2.93315,"twenty":-8.774451,"median":-3.554849,"eighty":-2.244949,"marketCap":350185861},{"date":"2025-01-17","current":-2.909994,"twenty":-8.716457,"median":-3.537764,"eighty":-2.246858,"marketCap":347421235},{"date":"2025-01-24","current":-2.840524,"twenty":-8.696552,"median":-3.533084,"eighty":-2.252886,"marketCap":339127360},{"date":"2025-01-31","current":-3.427154,"twenty":-8.648533,"median":-3.481473,"eighty":-2.255961,"marketCap":409164532},{"date":"2025-02-07","current":-3.468321,"twenty":-8.641906,"median":-3.479885,"eighty":-2.255972,"marketCap":414079421},{"date":"2025-02-14","current":-3.488905,"twenty":-8.615397,"median":-3.468321,"eighty":-2.258537,"marketCap":416536866},{"date":"2025-02-21","current":-3.200736,"twenty":-8.58,"median":-3.45803,"eighty":-2.258655,"marketCap":382132641},{"date":"2025-02-28","current":-2.830233,"twenty":-8.566135,"median":-3.433816,"eighty":-2.263087,"marketCap":337898638},{"date":"2025-03-07","current":-3.288216,"twenty":-8.557578,"median":-3.420884,"eighty":-2.267314,"marketCap":392576781},{"date":"2025-03-14","current":-3.226465,"twenty":-8.534545,"median":-3.414303,"eighty":-2.275625,"marketCap":385204447},{"date":"2025-03-21","current":-4.907248,"twenty":-8.502577,"median":-3.420884,"eighty":-2.277507,"marketCap":356756961},{"date":"2025-03-28","current":-4.314994,"twenty":-8.485464,"median":-3.4323,"eighty":-2.287949,"marketCap":313700087},{"date":"2025-04-04","current":-3.342005,"twenty":-8.408627,"median":-3.4323,"eighty":-2.29056,"marketCap":242963792},{"date":"2025-04-11","current":-3.570446,"twenty":-8.347657,"median":-3.433687,"eighty":-2.29141,"marketCap":259571444},{"date":"2025-04-17","current":-3.849652,"twenty":-8.330793,"median":-3.441536,"eighty":-2.291623,"marketCap":279869685},{"date":"2025-04-25","current":-4.281151,"twenty":-8.320951,"median":-3.45803,"eighty":-2.29727,"marketCap":311239694},{"date":"2025-05-02","current":-4.205004,"twenty":-8.309219,"median":-3.465749,"eighty":-2.303858,"marketCap":305703810},{"date":"2025-05-09","current":40.886587,"twenty":-8.268632,"median":-3.463176,"eighty":-2.29727,"marketCap":251575167},{"date":"2025-05-16","current":39.786947,"twenty":-8.207488,"median":-3.457335,"eighty":-2.285339,"marketCap":244809087},{"date":"2025-05-23","current":40.486718,"twenty":-8.16736,"median":-3.435333,"eighty":-2.261986,"marketCap":249114775},{"date":"2025-05-30","current":42.286127,"twenty":-8.132248,"median":-3.4323,"eighty":-2.255965,"marketCap":260186542},{"date":"2025-06-06","current":46.184849,"twenty":-8.07958,"median":-3.428999,"eighty":-2.240226,"marketCap":284175373},{"date":"2025-06-13","current":49.183865,"twenty":-8.031927,"median":-3.416863,"eighty":-2.219949,"marketCap":302628319},{"date":"2025-06-20","current":44.885275,"twenty":-7.993053,"median":-3.412507,"eighty":-2.203356,"marketCap":276179096},{"date":"2025-06-27","current":46.584717,"twenty":-7.986783,"median":-3.411516,"eighty":-2.169906,"marketCap":286635765},{"date":"2025-07-03","current":48.684029,"twenty":-7.981767,"median":-3.387058,"eighty":-2.154934,"marketCap":299552828},{"date":"2025-07-11","current":52.58275,"twenty":-7.950417,"median":-3.357685,"eighty":-2.141004,"marketCap":323541658},{"date":"2025-07-18","current":58.980651,"twenty":-7.85658,"median":-3.347149,"eighty":-2.117261,"marketCap":362907943},{"date":"2025-07-25","current":57.081274,"twenty":-7.837556,"median":-3.339901,"eighty":-2.110599,"marketCap":351221077},{"date":"2025-08-01","current":49.483766,"twenty":-7.714094,"median":-3.337926,"eighty":-2.090889,"marketCap":304473613},{"date":"2025-08-04","current":47.884291,"twenty":-7.70704,"median":-3.336303,"eighty":-2.088595,"marketCap":294632042}],"updateTime":1754447416041}}}